Scholars Central

Conference abstractPublished 20 Oct 2014

Int6/eIF3e is essential for proliferation and survival of humanglioblastoma cells

Authors: Julie Sesen, Anne Cammas, Sarah J Scotl, Bert, Elefterion, Anthony Lemarié, Stefania Millevoi, Lijoy K Mathew, Cathy Seva, Christine Toulas, Elizabeth Cohen-Jonathan Moyal, Nicolas Skuli

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Based on the World Health Organization classification, Glioblastoma Multiforme (GBM) are grade IV astrocytic brain tumors and are one of the most deadly human cancers. GBM are very aggressive, with frequent relapses despite an appropriate treatment combining surgery, chemotherapy and radiotherapy. In GBM, hypoxia is a characteristic feature and activation of Hypoxia Inducible Factors (HIF-1α and HIF-2α) has been associated with resistance to anti-cancer therapeutics. Int6, also named eIF3e, is the ?e? subunit of the translation initiation factor eIF3, and was identified as novel regulator of HIF-2α. Eukaryotic initiation factors (eIFs) are key factors regulating total protein synthesis, which controls cell growth, size and proliferation. The functional significance of Int6/eIF3e and the effect of Int6/EIF3E gene silencing on human brain GBM has not yet been described and its role on the HIFs is unknown in glioma cells. In the present work, we show that Int6/ eIF3e suppression affects survival of various GBM cells. We highlight that Int6 inhibition induces decreased proliferation through cell cycle arrest and increased autophagy and caspase-dependent and capase-independent cell death. Surprisingly, these phenotypes do not correlate with decreasedglobal cell translation, but could be, in part, explained by the decrease of HIF and HIF target expression in GBM cells. Indeed, isolation of polysome-bound mRNA reveals modulation of specific mRNA translation, such as HIF mRNA, when Int6 is silenced. Although a deeper understanding of the molecular mechanisms involved in this Int6/eIF3e-HIFs pathway is necessary, Int6 could become a new therapeutic option for these aggressive tumors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Julie Sesen”
  • BylineArticles whose byline prints “Anne Cammas”
  • BylineArticles whose byline prints “Sarah J Scotl”
  • BylineArticles whose byline prints “Bert”
  • BylineArticles whose byline prints “Elefterion”
  • BylineArticles whose byline prints “Anthony Lemarié”
  • BylineArticles whose byline prints “Stefania Millevoi”
  • BylineArticles whose byline prints “Lijoy K Mathew”